Название документа

tablets "Dekaris" are applied at the following indications:

  • ascaridosis;
  • necatoriasis;
  • ankilostomidoz.

Structure

Active ingredient - levamisole (one tablet contains levamisole 50 mg (in the form of 59 mg of levamisole of a hydrochloride)).

Excipients: starch corn, sodium saccharin, povidone, talc, aroma apricot, magnesium stearate, yellow decline of FCF (E 110).

Contraindication

Hypersensitivity to levamisole or to any excipient which is a part of medicine.

Route of administration

by

to Children medicament is appointed in the form of tablets on 50 mg once (evening) in a dose of 2.5 mg/kg of body weight:

  • 3-6 years (body weight - 10-20 kg) - 25-50 mg (1/2-1 tablet);
  • 7-10 years (body weight - 20-30 kg) - 50-75 mg (1-1.5 tablets);
  • 11-18 years (body weight - 30-60 kg) - 75-100 mg (1.5-3 tablets).
to use

Tablet to children according to purpose and under observation of the doctor.

it is reasonable to p to take the Drug with a small amount of water after meal of evening.

does not have

In use of depletive or a special diet need.

In case of need treatment is repeated after a 7-14-day break.

Feature of use

Pregnant women

In a research on animals did not observe teratogenic action. Well controlled researches with the assistance of pregnant women were not conducted therefore during pregnancy it is only possible to appoint the medicament "Dekaris" if the expected advantage exceeds possible risk of use of drug.

Does not know to

whether levamisole gets into breast milk of the woman, however it was defined in cow's milk. For prevention of negative impact on the baby it is necessary to resolve an issue of need of administration of medicament for the woman who nurses.

Reproductive researches on animals did not show to

influence on fertility.

to

Drivers

by

it is not proved that levamisole affects ability to drive the car or other mechanisms though it was reported about encephalopathy as very rare side reaction at treatment by levamisole.

by

Overdose

At reception of a high dose of levamisole (over 600 mg) described such symptoms of intoxication: nausea, vomiting, lethargy, spasms, diarrhea, headache, dizziness and confusion of consciousness. At the doses exceeding recommended it was reported about convulsion.

Treatment: at accidental overdose if after reception there passed a little time, it is necessary to wash out a stomach. Monitoring of vital indicators and performing symptomatic therapy is necessary. In case of presence of signs of antikholinesterazny action it is possible to enter atropine as antidote.

Side effects

from a cardiovascular system: heart consciousness.

from the system of blood and lymphatic system: agranulocytosis, leukopenia.

Mental disorders: insomnia.

from the central nervous system: spasms, dizziness, encephalopathy, headache.

from digestive tract: abdominal pain, diarrhea, nausea, vomiting.

from the immune system: reactions of hypersensitivity, including rash, an itching and a Quincke's disease.

Storage conditions

to Store

at a temperature not above 25 °C, out of children's reach.

Expiration date - 5 years.

Characteristics
Active ingredients Levamisole
Amount of active ingredient 50 mg
Applicant Gideon Richter
Code of automatic telephone exchange P02CE01 Levamisole
Interaction with food Later
Light sensitivity Not sensitive
Market status The branded generic
Origin Chemical
Prescription status Without prescription
Primary packing blister
Producer GIDEON RICHTER OF JOINT STOCK COMPANY
Quantity in packing 2 tablets
Release form tablets for internal use
Route of administration Oral
Sign Import
Storage temperature from 15 °C to 30 °C
Trade name Decarice

Reviews Decarice of the tab. of 50 mg No. 2

5 Rating 1 Reviews

Quality
Speed
Delivery
Performance
Price

Decarice of the tab. of 50 mg No. 2

  • Product Code: 182934
  • In Stock

  • Ready to ship
  • $23.41


Related Products

Last Viewed

Модули для Opencart